共 124 条
[1]
Marrero JA(2018)Management of hepatocellular carcinoma J Hepatol 69 182-236
[2]
Kulik LM(2018)Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases Hepatology 68 723-750
[3]
Sirlin CB(2014)CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features Radiology 273 30-50
[4]
Zhu AX(2015)Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis Radiology 275 97-109
[5]
Finn RS(2017)Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update Hepatol Int 11 317-370
[6]
Abecassis MM(2015)Noninvasive diagnosis of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout? Eur Radiol 25 2859-2868
[7]
Choi JY(2018)Imaging for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis Hepatology 67 401-421
[8]
Lee JM(2018)Prospective intraindividual comparison of magnetic resonance imaging with gadoxetic acid and extracellular contrast for diagnosis of hepatocellular carcinomas using the liver imaging reporting and data system Hepatology 68 2254-2266
[9]
Sirlin CB(2020)Comparison of extracellular and hepatobiliary MR contrast agents for the diagnosis of small HCCs J Hepatol 72 937-945
[10]
Lee YJ(2009)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration Ann Intern Med 151 W65-94